vs
Side-by-side financial comparison of HANMI FINANCIAL CORP (HAFC) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
HANMI FINANCIAL CORP is the larger business by last-quarter revenue ($71.2M vs $57.2M, roughly 1.2× Vanda Pharmaceuticals Inc.). HANMI FINANCIAL CORP runs the higher net margin — 29.8% vs -246.8%, a 276.6% gap on every dollar of revenue. On growth, HANMI FINANCIAL CORP posted the faster year-over-year revenue change (17.1% vs 7.6%). HANMI FINANCIAL CORP produced more free cash flow last quarter ($203.7M vs $-29.5M). Over the past eight quarters, HANMI FINANCIAL CORP's revenue compounded faster (10.4% CAGR vs 9.8%).
Hanmi Bank Corporation is a community bank headquartered in Los Angeles, California, with 35 branches and eight loan production offices in California, Texas, Illinois, New York, New Jersey and Virginia.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
HAFC vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.2M | $57.2M |
| Net Profit | $21.2M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 29.8% | -70.5% |
| Net Margin | 29.8% | -246.8% |
| Revenue YoY | 17.1% | 7.6% |
| Net Profit YoY | 20.0% | -2774.3% |
| EPS (diluted) | $0.70 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.2M | $57.2M | ||
| Q3 25 | $71.0M | $56.3M | ||
| Q2 25 | $65.2M | $52.6M | ||
| Q1 25 | $62.8M | $50.0M | ||
| Q4 24 | $60.8M | $53.2M | ||
| Q3 24 | $58.5M | $47.7M | ||
| Q2 24 | $56.7M | $50.5M | ||
| Q1 24 | $58.4M | $47.5M |
| Q4 25 | $21.2M | $-141.2M | ||
| Q3 25 | $22.1M | $-22.6M | ||
| Q2 25 | $15.1M | $-27.2M | ||
| Q1 25 | $17.7M | $-29.5M | ||
| Q4 24 | $17.7M | $-4.9M | ||
| Q3 24 | $14.9M | $-5.3M | ||
| Q2 24 | $14.5M | $-4.5M | ||
| Q1 24 | $15.2M | $-4.1M |
| Q4 25 | 29.8% | -70.5% | ||
| Q3 25 | 31.1% | -55.6% | ||
| Q2 25 | 23.2% | -73.2% | ||
| Q1 25 | 28.1% | -82.0% | ||
| Q4 24 | 29.1% | -19.3% | ||
| Q3 24 | 25.5% | -23.1% | ||
| Q2 24 | 25.5% | -20.1% | ||
| Q1 24 | 26.0% | -19.5% |
| Q4 25 | 29.8% | -246.8% | ||
| Q3 25 | 31.1% | -40.1% | ||
| Q2 25 | 23.2% | -51.7% | ||
| Q1 25 | 28.1% | -58.9% | ||
| Q4 24 | 29.1% | -9.2% | ||
| Q3 24 | 25.5% | -11.2% | ||
| Q2 24 | 25.5% | -9.0% | ||
| Q1 24 | 26.0% | -8.7% |
| Q4 25 | $0.70 | $-2.40 | ||
| Q3 25 | $0.73 | $-0.38 | ||
| Q2 25 | $0.50 | $-0.46 | ||
| Q1 25 | $0.58 | $-0.50 | ||
| Q4 24 | $0.58 | $-0.09 | ||
| Q3 24 | $0.49 | $-0.09 | ||
| Q2 24 | $0.48 | $-0.08 | ||
| Q1 24 | $0.50 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $796.4M | $327.2M |
| Total Assets | $7.9B | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | $796.4M | $327.2M | ||
| Q3 25 | $779.5M | $466.0M | ||
| Q2 25 | $762.8M | $486.3M | ||
| Q1 25 | $751.5M | $511.4M | ||
| Q4 24 | $732.2M | $538.5M | ||
| Q3 24 | $736.7M | $541.2M | ||
| Q2 24 | $707.1M | $542.5M | ||
| Q1 24 | $703.1M | $544.0M |
| Q4 25 | $7.9B | $488.9M | ||
| Q3 25 | $7.9B | $601.1M | ||
| Q2 25 | $7.9B | $624.7M | ||
| Q1 25 | $7.7B | $631.9M | ||
| Q4 24 | $7.7B | $656.2M | ||
| Q3 24 | $7.7B | $645.1M | ||
| Q2 24 | $7.6B | $651.4M | ||
| Q1 24 | $7.5B | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.0M | $-29.4M |
| Free Cash FlowOCF − Capex | $203.7M | $-29.5M |
| FCF MarginFCF / Revenue | 286.2% | -51.6% |
| Capex IntensityCapex / Revenue | 3.2% | 0.2% |
| Cash ConversionOCF / Net Profit | 9.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $356.1M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.0M | $-29.4M | ||
| Q3 25 | $146.9M | $-31.6M | ||
| Q2 25 | $-19.0M | $-15.3M | ||
| Q1 25 | $25.8M | $-33.1M | ||
| Q4 24 | $52.6M | $-1.8M | ||
| Q3 24 | $6.7M | $-14.6M | ||
| Q2 24 | $2.1M | $-6.9M | ||
| Q1 24 | $30.0M | $7.6M |
| Q4 25 | $203.7M | $-29.5M | ||
| Q3 25 | $146.4M | $-31.8M | ||
| Q2 25 | $-19.6M | $-15.6M | ||
| Q1 25 | $25.6M | $-33.6M | ||
| Q4 24 | $49.9M | $-2.0M | ||
| Q3 24 | $6.5M | $-14.7M | ||
| Q2 24 | $1.3M | $-7.0M | ||
| Q1 24 | $29.2M | $7.6M |
| Q4 25 | 286.2% | -51.6% | ||
| Q3 25 | 206.3% | -56.5% | ||
| Q2 25 | -30.0% | -29.6% | ||
| Q1 25 | 40.7% | -67.1% | ||
| Q4 24 | 82.1% | -3.8% | ||
| Q3 24 | 11.1% | -30.9% | ||
| Q2 24 | 2.3% | -13.9% | ||
| Q1 24 | 50.0% | 15.9% |
| Q4 25 | 3.2% | 0.2% | ||
| Q3 25 | 0.8% | 0.3% | ||
| Q2 25 | 0.9% | 0.6% | ||
| Q1 25 | 0.4% | 0.9% | ||
| Q4 24 | 4.3% | 0.4% | ||
| Q3 24 | 0.4% | 0.3% | ||
| Q2 24 | 1.4% | 0.2% | ||
| Q1 24 | 1.4% | 0.0% |
| Q4 25 | 9.70× | — | ||
| Q3 25 | 6.66× | — | ||
| Q2 25 | -1.26× | — | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 2.97× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 1.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAFC
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
